Application 216775
- Type
- ANDA
- Sponsor
- ALEMBIC PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACALABRUTINIB | ACALABRUTINIB | CAPSULE;ORAL | 100MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CALQUENCE | ACALABRUTINIB | AstraZeneca Pharmaceuticals LP | b1409184-3267-4d8c-8f17-4e01f69828b1 | 2026-02-19 | Warnings, Adverse reactions | ACALABRUTINIB |
| CALQUENCE | ACALABRUTINIB | AstraZeneca Pharmaceuticals LP | dd4835ef-e1bc-4997-a399-1ffa2556fbfe | 2026-02-19 | Warnings, Adverse reactions | ACALABRUTINIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 73416 | ORIG | 2023-02-08 |